603 8. Miscellanea Bibliografia [1] Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472–1475. [2] Nazlıhan Boyacı, Gulbin Aygencel, Melda Turkoglu, Zeynep Arzu Yegin, Kadir Acar & Gulsan Turkoz Sucak (2014) The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis, Hematology, 19:6, 338-345, DOI: 10.1179/1607845413Y.0000000130 [3] Tugba Barlas, Kamil İnci, Gulbin Aygencel, Melda Turkoglu, Ozlem Guzel Tunccan, Ferda Can, Lale Aydın Kaynar, Zubeyde Nur Ozkurt, Zeynep Arzu Yegin & Munci Yagcı (2021) Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study, Hematology, 26:1, 328339, DOI: 10.1080/16078454.2021.1905355 [4] Naeem N, Reed MD, Creger RJ, Youngner SJ, Lazarus HM. Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter? Bone Marrow Transplant 2006; 37: 119–133. [5] Afessa B, Peters SG. Major complications following hemato- poietic stem cell transplantation. Semin Respir Crit Care Med. 2006;27(3):297–309 [6] Matulis M, High KP. Immune reconstitution after hematopoietic stem-cell trans- plantation and its influence on respiratory infections. Semin Respir Infect 2002; 17(2):130–9. [7] Azoulay E, Pene F, Darmon M, Lengline E, Benoit D, Soares M et al. Managing critically Ill hematology patients: time to think differently. Blood Rev 2015; 29: 359–367. [8] Saillard C, Blaise D, Mokart D. Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant. 2016 Aug;51(8):1050-61. doi: 10.1038/bmt.2016.72. Epub 2016 Apr 4. PMID: 27042832. [9] Vink EE, Azoulay E, Caplan A, Kompanje EJO, Bakker J. Time-limited trial of intensive care treatment: an overview of current literature. Intensive Care Med. 2018 Sep;44(9):1369-1377. doi: 10.1007/ s00134-018-5339-x. Epub 2018 Aug 22. PMID: 30136140 [10] Mokart D, Lambert J, Schnell D, et al. Delayed inten- sive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 2013; 54: 1724–1729 [11] Taheri L, Anandanadesan R, de Lavallade H, Pagkalidou E, Pagliuca A, Mufti G, Auzinger G, Metaxa V. The role of a critical care outreach service in the management of patients with haematological malignancy. J Intensive Care Soc. 2019 Nov;20(4):327-334. doi: 10.1177/1751143719855201. Epub 2019 Jun 10. PMID: 31695737; PMCID: PMC6820225. [12] Afessa B, Azoulay E. Critical care of the hematopoietic stem cell transplant recipient. Crit Care Clin. 2010;26(1):133–50. [13] Constantinescu C, Bodolea C, Pasca S, Teodorescu P, Dima D, Rus I, Tat T, Achimas-Cadariu P, Tanase A, Tomuleasa C, Einsele H. Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician. J Clin Med. 2019 Jun 20;8(6):884. doi: 10.3390/ jcm8060884. PMID: 31226876; PMCID: PMC6616972. [14] Harvey S, Young D, Brampton W, et al. Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev 2006;(3):CD003408. [15] Azoulay E, Mokart D, Rabbat A, et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 2008;36(1):100–7. [16] Guidelines-for-Referral-to-and-Care-of-SCT-Patients-in-the-Intensive-Care-Unit-(DCCM-PICU)_2019-01- 22. [17] Ariza-Hereida, E.J. And Chemaly, R.F.(2018), Update on infection control practices in cancer hospitals. CA: A Cancer journal for Clinicians, 68:340-355. [18] Soubani AO, Kseibi E, Bander JJ, et al. Outcome and prognostic factors of hema- topoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004;126(5):1604–11. [19] Lemiale V, Mokart D, Resche-Rigon M, et al. Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA 2015; 314: 1711–1719. [20] Lemiale V, Resche-Rigon M, Mokart D, et al. High-flow nasal cannula oxygenation in immunocom- promised patients with acute hypoxemic respiratory failure: a Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique Study. Crit Care Med 2017; 45: e274–e280. [21] DeNardo SJ, Oye RK, Bellamy PE. Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med 1989;17(1):4–6. [22] Sedhom R, Sedhom D, Jaimes E. Mini-review of kidney dis- ease following hematopoietic stem cell transplant. Clin Nephrol. 2018;89(6):389–402 [23] Karkar A, Ronco C. Prescription of CRRT: a pathway to optimize therapy. Ann Intensive Care. 2020;10(1):32. Published 2020 Mar 6. doi:10.1186/s13613-020-0648-y [24] Naeem N, Eyzaguirre A, Kern JA, et al. Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit. Bone Marrow Trans- plant 2006;38(11):733–8. [25] Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):1368–77. [26] Harnisch LO, Moerer O. Contraindications to the Initiation of Veno-Venous ECMO for Severe Acute Respiratory Failure in Adults: A Systematic Review and Practical Approach Based on the Current Literature. Membranes (Basel). 2021;11(8):584. Published 2021 Jul 30. doi:10.3390/membranes11080584 [27] Di Nardo M, Ahmad AH, Merli P, Zinter MS, Lehman LE, Rowan CM, Steiner ME, Hingorani S, Angelo JR, Abdel-Azim H, Khazal SJ, Shoberu B, McArthur J, Bajwa R, Ghafoor S, Shah SH, Sandhu H, Moody K, Brown BD, Mireles ME, Steppan D, Olson T, Raman L, Bridges B, Duncan CN, Choi SW, Swinford R, Paden M, Fortenberry JD, Peek G, Tissieres P, De Luca D, Locatelli F, Corbacioglu S, Kneyber M, Franceschini A, Nadel S, Kumpf M, Loreti A, Wösten-Van Asperen R, Gawronski O, Brierley J, MacLaren G, Mahadeo KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. Lancet Child Adolesc Health. 2022 Feb;6(2):116-128. doi: 10.1016/S23524642(21)00336-9. Epub 2021 Dec 9. PMID: 34895512. [28] Ghafoor S, Fan K, Di Nardo M, Talleur AC, Saini A, Potera RM, Lehmann L, Annich G, Wang F, McArthur J, Sandhu H. Extracorporeal Membrane Oxygenation Candidacy in Pediatric Patients Treated With Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy: An International Survey. Front Oncol. 2021 Dec 22;11:798236. doi: 10.3389/fonc.2021.798236. PMID: 35004323; PMCID: PMC8727600. [29] Slooff, V., Hoogendoorn, R., Nielsen, J.S.A. et al. Role of extracorporeal membrane oxygenation in pediatric cancer patients: a systematic review and meta-analysis of observational studies. Ann. Intensive Care 12, 8 (2022). https://doi.org/10.1186/s13613-02200983-0. [30] Thiery G, Azoulay E, Darmon M, Ciroldi M, De MS, Levy V et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406–4413. [31] Lengline E, Chevret S, Moreau AS, Pene F, Blot F, Bourhis JH et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2015; 50: 840– 845. [32] Mokart D, Granata A, Roberto C, Sannini A, Chow-Chine L, Brun JP et al. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care 2015; 30: 1107–1113. [33] Lecuyer L, Chevret S, Guidet B, Aegerter P, Martel P, Schlemmer B et al. Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 2008; 32: 748–754. [34] Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808–814.
RkJQdWJsaXNoZXIy ODUzNzk5